SUE ELLEN BOWES: Open Payments
NPI 1285170274 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,070 in 42 payments from 14 companies in 2025. Trend: 2023 $1,782 · 2024 $1,605 · 2025 $1,070
Food & beverage: $1,070
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $436 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $125 |
| Amgen Inc. | 4 | $79 |
| JAZZ PHARMACEUTICALS INC. | 3 | $68 |
| GENZYME CORPORATION | 2 | $58 |
| Mallinckrodt Hospital Products Inc. | 2 | $58 |
| Grifols USA, LLC | 2 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Insmed, Inc. | 1 | $32 |
Products named: NUCALA, LUMRYZ, TRELEGY ELLIPTA, TEZSPIRE, DUPIXENT, XYWAV, ACTHAR, Prolastin-C Liquid.
Industry payments across NC — which companies pay providers there.
